Does Comorbid Anxiety or Depression Moderate Effects of Approach Bias Modification in the Treatment of Alcohol Use Disorders?

被引:20
|
作者
Salemink, Elske [1 ]
Rinck, Mike [2 ,3 ]
Becker, Eni [2 ]
Wiers, Reinout W. [4 ]
Lindenmeyer, Johannes [5 ]
机构
[1] Univ Utrecht, Dept Clin Psychol, Expt Psychopathol EPP Lab, POB 80140, NL-3508 TC Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Behav Sci Inst, Dept Clin Psychol, Nijmegen, Netherlands
[3] Ruhr Univ, Dept Clin Psychol & Psychotherapy, Bochum, Germany
[4] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol Adapt Lab, ABC & Yield Res Prior Areas, Amsterdam, Netherlands
[5] Lindow & Med Sch, Salus Clin, Brandenburg, Germany
关键词
approach bias modification; alcohol dependence; comorbid anxiety disorder; comorbid major depressive disorder; relapse prevention; IDENTIFICATION TEST AUDIT; ACTION-TENDENCIES; SUBSTANCE USE; DEPENDENCE; RELIABILITY; PREVALENCE; ADDICTION; VALIDITY;
D O I
10.1037/adb0000642
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Approach bias modification (ApBM) is a promising new add-on training intervention for patients with alcohol use disorder (AUD). Given that comorbid anxiety and major depressive disorders are very common in AUD, and that such comorbidity affects psychological treatments negatively, the primary aim of the present study was investigating whether ApBM training is moderated by anxiety/major depressive disorder comorbidity. The secondary aim was to examine whether ApBM's relapse-preventive effect can be replicated. Method: We conducted a large-scale randomized controlled trial (RCT) in a clinical sample of AUD inpatients (n = 729) with a follow-up assessment after 1 year. All patients received 12 weeks of inpatient treatment as usual (TAU). On top of that, patients were randomized to a 12-session ApBM (TAU + ApBM), and a no-training control condition (TAU-only). Treatment success was defined as either no relapse or a single lapse shorter than 3 days in duration, ended by the patient and followed by at least 4 weeks of abstinence. Failure was defined as relapse, passed away, no contact, or refusal to provide information. Results: We found that TAU + ApBM had significantly higher success rates than TAU-only at 1-year follow-up. Importantly, anxiety/depressive comorbidity moderated ApBM's effects: Adding ApBM to TAU increased success rates more for patients with a comorbid anxiety and/or depressive disorder than for patients without such comorbidity. Conclusions: Our data suggest that adding ApBM to TAU works better in patients with a comorbid anxiety and/or depressive disorder; a promising finding gave the high rates of comorbidity in clinical practice. Public Health Significance Statement This study indicates that patients with an alcohol use disorder (AUD) who received standard care plus training to avoid alcohol cues had less relapse into drinking about a year later compared to patients who only received standard care. This study indicates that among patients with an AUD, it is particularly those who have an additional anxiety or major depressive disorder, who benefit from the alcohol-avoid training.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 50 条
  • [1] DOES GENDER MODERATE THE EFFECTS OF COMORBID ALCOHOL USE DISORDERS AND MAJOR DEPRESSION ON ALCOHOL INVOLVEMENT?
    Cranford, J. A.
    Nolen-Hoeksema, S.
    McCabe, S. E.
    Zucker, R. A.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 247A - 247A
  • [2] Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
    Kaufmann, Christopher N.
    Chen, Lian-Yu
    Crum, Rosa M.
    Mojtabai, Ramin
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2014, 49 (09) : 1489 - 1499
  • [3] Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
    Christopher N. Kaufmann
    Lian-Yu Chen
    Rosa M. Crum
    Ramin Mojtabai
    [J]. Social Psychiatry and Psychiatric Epidemiology, 2014, 49 : 1489 - 1499
  • [4] On the Use of Cognitive Bias Modification in the Treatment of Alcohol Use Disorders
    Wiers, Reinout
    [J]. PHARMACOLOGICAL REPORTS, 2019, 71 (06) : 1316 - 1316
  • [5] Pharmacotherapy for anxiety and comorbid alcohol use disorders
    Ipser, Jonathan C.
    Wilson, Don
    Akindipe, Taiwo O.
    Sager, Carli
    Stein, Dan J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [6] PHARMACOLOGICAL TREATMENT OF DEPRESSION AND COMORBID ANXIETY DISORDERS
    CASSANO, GB
    MICHELINI, S
    [J]. DEPRESSION AND MANIA: FROM NEUROBIOLOGY TO TREATMENT, 1995, 49 : 113 - 125
  • [7] EFFECTS OF COMORBID ANXIETY DISORDERS ON TREATMENT OF DEPRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS
    Burns, Michelle N.
    Fokuo, Konadu
    Mohr, David
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 148 - 148
  • [8] The impact of comorbid anxiety and depression on alcohol treatment outcomes
    Burns, L
    Teesson, M
    O'Neill, K
    [J]. ADDICTION, 2005, 100 (06) : 787 - 796
  • [9] Comorbid interpretation and expectancy bias in social anxiety and alcohol use
    Chow, Philip I.
    Portnow, Sam
    Zhang, Diheng
    Salemink, Elske
    Wiers, Reinout W.
    Teachman, Bethany A.
    [J]. ANXIETY STRESS AND COPING, 2018, 31 (06): : 669 - 685
  • [10] Recognition and treatment of depression with or without comorbid anxiety disorders
    Zimmerman, M
    Chelminski, I
    Zisook, S
    Ginsberg, DL
    [J]. CNS SPECTRUMS, 2006, 11 (01) : A1 - A1